הרופא/ה פירסם את המחקרים והמאמרים הבאים
Lancet 2023 Jan 2840110373269-280Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis MOMENTUM results from an international double-blind randomised controlled phase 3 study
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma N Engl J Med 2022 Vol 386262482-2494